Paul L. Wood

Paul L. Wood publications per year

Paul L. Wood publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Paul L. Wood sits on this spectrum.

Paul L. Wood D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Paul L. Wood sits on this spectrum.

Research.com Recognitions

• 1971 - Fellow of the American Association for the Advancement of Science (AAAS)

Best Publications

• Neurobiology of 50-kHz ultrasonic vocalizations in rats: Electrode mapping, lesion, and pharmacology studies

  Jeffrey Burgdorf;Paul L. Wood;Roger A. Kroes;Joseph R. Moskal

  463
  Citations

• Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1β or IL-1RA but increases in the associated acute phase proteins IL-6, α2-macroglobulin and C-reactive protein

  Julie A. Wood;Paul L. Wood;Randall Ryan;Neill R. Graff-Radford

  355
  Citations

• Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptor.

  Richard B. Carter;Paul L. Wood;Scott Wieland;Jon E. Hawkinson

  346
  Citations

• Nucleus basalis neuronal loss, neuritic plaques and choline acetyltransferase activity in advanced Alzheimer's disease.

  P. Etienne;P. Etienne;Y. Robitaille;P. Wood;S. Gauthier

  296
  Citations

• Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer's disease and dementia.

  Dayan B. Goodenowe;Lisa L. Cook;Jun Liu;Yingshen Lu

  294
  Citations

• Multiple opiate receptors: Differential binding of μ, κ and δ agonists

  P.L. Wood;Stella E. Charleson;D. Lane;R.L. Hudgin

  268
  Citations

• Reduced lumbar CSF somatostatin in levels in Alzheimer's disease

  Paul L. Wood;P. Etienne;S. Lal;S. Gauthier

  252
  Citations

• Inhibition of Nitric Oxide Synthase Blocks N‐Methyl‐D‐Aspartate‐, Quisqualate‐, Kainate‐, Harmaline‐, and Pentylenetetrazole‐Dependent Increases in Cerebellar Cyclic GMP In Vivo

  Paul L. Wood;Mark R. Emmett;Tadimeti S. Rao;Julie Cler

  214
  Citations

• Circulating plasmalogen levels and Alzheimer Disease Assessment Scale-Cognitive scores in Alzheimer patients.

  Paul L. Wood;Rishikesh Mankidy;Shawn Ritchie;Doug Heath

  205
  Citations

• Dopamine release in vivo from nigrostriatal, mesolimbic, and mesocortical neurons: utility of 3-methoxytyramine measurements.

  Unknown

  204
  Citations

• Modulation of the turnover rate of acetylcholine in rat brain by intraventricular injections of thyrotropin-releasing hormone, somatostatin, neurotensin and angiotensin II.

  D. Malthe-Sorenssen;P. L. Wood;D. L. Cheney;E. Costa

  199
  Citations

• Dopaminergic control of the septal-hippocampal cholinergic pathway.

  S E Robinson;D Malthe-Sørenssen;P L Wood;J Commissiong

  194
  Citations

• Enkephalinase: selective peptide inhibitors.

  Roger L. Hudgin;Stella E. Charleson;M. Zimmerman;R. Mumford

  179
  Citations

• Microglia as a unique cellular target in the treatment of stroke: Potential neurotoxic mediators produced by activated microglia

  Unknown

  163
  Citations

• Interactions of phencyclidine receptor agonist MK-801 with dopaminergic system: regional studies in the rat.

  Tadimeti S. Rao;Helen S. Kim;John Lehmann;Louis L. Martin

  162
  Citations

• Changes of hippocampal Met-enkephalin content after recurrent motor seizures

  J. S. Hong;P. L. Wood;J. C. Gillin;H. Y. T. Yang

  159
  Citations

• Non-targeted lipidomics of CSF and frontal cortex grey and white matter in control, mild cognitive impairment, and Alzheimer's disease subjects.

  Paul L. Wood;Brooke L. Barnette;Jeffrey A. Kaye;Joseph F. Quinn

  151
  Citations

• Normalization of platelet [3H]imipramine binding in depressed patients during remission

  Barbara E. Suranyi-Cadotte;Paul L. Wood;N.P. Vasavan Nair;George Schwartz

  146
  Citations

• In vivo modulation of the N-methyl-D-aspartate receptor complex by D-serine: potentiation of ongoing neuronal activity as evidenced by increased cerebellar cyclic GMP.

  Paul L. Wood;Mark R. Emmett;Tadimeti S. Rao;Steve Mick

  145
  Citations

• GLYX-13: a monoclonal antibody-derived peptide that acts as an N-methyl-D-aspartate receptor modulator.

  Joseph R. Moskal;Amy G. Kuo;Craig Weiss;Paul L. Wood

  131
  Citations